Search
Menu
Gentec Electro-Optics Inc   - Measure With Gentec Accuracy LB

FDA Clears Laser for Diabetes Monitoring

Facebook X LinkedIn Email
There's good news for diabetics who draw blood to monitor their glucose levels. The US Food and Drug Administration (FDA) has approved the Lasette, a battery-operated Er:YAG laser that can extract blood without the pain associated with metal lancets, for home use. Cell Robotics International Inc. in Albuquerque, N.M., manufactures the device.

Clinical tests revealed that patients who received adequate training with this device were able to perform pinpricks as easily as with lancets. It was effective with both adults and juveniles who have diabetes, a chronic disease that afflicts 15.7 million people in the US.

In the wake of the FDA's clearance, Cell Robotics' stock more than doubled, increasing from $1.81 Dec. 7 to $3.69 Dec. 9.
PI Physik Instrumente - Revolution In Photonics Align ROS MR 3/24

Published: January 1999
As We Go To PressBreaking NewsPresstime BulletinLasers

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.